Quetiapine Fumarate Tablet
Product Images NDC 70518-1918

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Quetiapine Fumarate (NDC 70518-1918). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

156f500b 643d 4f44 9963 C65d2ec23f37 01

156f500b 643d 4f44 9963 C65d2ec23f37 01
Chemical structure of quetiapine fumarate, showing the molecular arrangement including heterocyclic rings and side groups characteristic of the compound.*
FDA Label Image

156f500b 643d 4f44 9963 C65d2ec23f37 02

156f500b 643d 4f44 9963 C65d2ec23f37 02
A Kaplan-Meier survival curve chart showing the proportion of patients with relapse (%) over time (weeks) for two groups: QTP+LI/VAL (quetiapine fumarate plus lithium/valproate) and PLA+LI/VAL (placebo plus lithium/valproate). The chart depicts relapse rates increasing over time, with the placebo group showing a higher proportion of relapse compared to the quetiapine fumarate group.*
FDA Label Image

156f500b 643d 4f44 9963 C65d2ec23f37 03

156f500b 643d 4f44 9963 C65d2ec23f37 03
A Kaplan-Meier curve showing the proportion of patients with relapse over time in weeks. Two groups are compared: one treated with quetiapine fumarate plus lithium/valproate (QTP+LI/VAL) represented by a dashed line, and the other with placebo plus lithium/valproate (PLA+LI/VAL) represented by a solid line. The graph depicts relapse rates reaching about 30% and 65%, respectively, by week 100.*
FDA Label Image

Remedy_label (Remedy Label)

Remedy_label (Remedy Label)
Label for Quetiapine fumarate 200 mg oral tablet, quantity 30, labeled RX only. The label shows the NDC number 70518-1918-00 and states repackaging by RemedyRepack Inc. It includes storage instructions and a warning to keep medication out of reach of children. The original manufacturer is Lupin Pharma, Baltimore, MD.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.